Dr Juneko Grilley-Olson Discusses New Findings, Future Directions for Alliance A091902 Trial in Angiosarcoma
The Alliance A091902 trial is currently investigating paclitaxel with and without nivolumab in patients who are taxane naive and nivolumab plus cabozantinib in taxane-pretreated patients.
United States Juneko Grilley Olson Duke University School Of Medicine Alliance Network Duke Cancer Institute American Society Of Clinical Oncology
Source: ajmc.com